Skip to main content
    E

    Ernexa Therapeutics Inc. (ERNA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.65
    -0.03 (-1.79%)

    Market Cap: $2.84M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Ernexa Therapeutics Inc. (ERNA) Earnings: Report Dates and Results

    Updated Nov 6, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Ernexa Therapeutics (ERNA) is expected to report earnings on Mar 11, 2027. In the quarter ended Sep 30, 2026, Ernexa Therapeutics reported EPS of -$1.89, above the -$3.84 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    36%(8/22)
    Avg Surprise
    -74.59%
    Streak
    1 Q

    Upcoming Estimates

    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    ERNA has an expected report date of Mar 11, 2027. No consensus estimate is on file yet for the quarter ending Mar 31, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, ERNA beat 8, missed 13 and matched 1. The widest gap in the table came in the quarter ended Mar 31, 2023, when EPS landed 785.71% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$1.89-$3.84-$3.84 - -$3.84+50.78%BeatN/A10 up, 0 downNov 6, 2026N/A
    Jun 30, 2026-$3.40-$3.30-$3.30 - -$3.30-3.03%MissN/A10 up, 0 downAug 6, 2026N/A
    Mar 31, 2026-$6.95-$1.95N/A-256.41%MissN/AN/AN/AMay 11, 2026N/A
    Dec 31, 2025-$4.81N/AN/AN/AN/AN/AN/AN/AMar 13, 2026N/A
    Sep 30, 2025-$0.15N/AN/AN/AN/AN/AN/AN/ANov 7, 2025N/A
    Jun 30, 2025-$0.61N/AN/AN/AN/AN/AN/AN/AAug 13, 2025N/A
    Mar 31, 2025-$2.31N/AN/AN/AN/AN/AN/AN/AMay 7, 2025N/A
    Dec 31, 2024-$0.15N/AN/AN/AN/AN/AN/A0 up, 0 downMar 13, 2025$1000
    Sep 30, 2024-$1,844.09N/AN/AN/AN/AN/AN/A0 up, 0 downNov 12, 2024$487000
    Jun 30, 2024-$383.80N/AN/AN/AN/AN/AN/A0 up, 0 downAug 13, 2024$47000
    Mar 31, 2024-$460.74N/AN/AN/AN/AN/AN/A0 up, 0 downMay 13, 2024$47000
    Dec 31, 2023-$427.06N/AN/AN/AN/AN/AN/A0 up, 0 downMar 13, 2024$17000
    Sep 30, 2023-$1.03N/AN/AN/AN/AN/AN/AN/ANov 13, 2023$51000
    Jun 30, 2023-$0.85N/AN/AN/AN/AN/AN/AN/AAug 11, 2023N/A
    Mar 31, 2023-$1.24-$0.14N/A-785.71%MissN/AN/A0 up, 0 downMay 11, 2023N/A
    Dec 31, 2022-$1.24-$0.14N/A-785.71%MissN/AN/A0 up, 0 downMar 20, 2023N/A
    Sep 30, 2022-$933.75-$825.00N/A-13.18%MissN/A10 up, 0 downNov 14, 2022N/A
    Jun 30, 2022-$450.00-$975.00N/A+53.85%BeatN/AN/AN/AJul 1, 2022N/A
    Mar 31, 2022-$3.20-$3.13N/A-2.35%Miss-16100.0%N/AN/AApr 15, 2022N/A
    Dec 31, 2021-$3.20-$3.13N/A-2.35%Miss-3300.0%N/AN/ADec 31, 2021N/A
    Sep 30, 2021-$12,749.99-$12,000.00N/A-6.25%Miss-63750050.0%N/AN/ANov 9, 2021N/A
    Jun 30, 2021-$0.24N/AN/AN/AN/A-1300.0%N/AN/AAug 13, 2021N/A
    Mar 31, 2021$0.02N/AN/AN/AN/A0.0%N/AN/AMay 17, 2021N/A
    Dec 31, 2020$0.10N/AN/AN/AN/AN/AN/AN/AMar 11, 2021$5.80M
    Sep 30, 2020$0.02N/AN/AN/AN/AN/AN/AN/ANov 11, 2020N/A
    Jun 30, 2020$0.02N/AN/AN/AN/AN/AN/AN/AAug 7, 2020N/A
    Mar 31, 2020$0.02N/AN/AN/AN/AN/AN/AN/AMay 19, 2020$2.39M
    Dec 31, 2019-$0.45$0.01N/AN/AN/A-110.2%N/AN/AMar 19, 2020$9.75M
    Sep 30, 2019-$0.12-$0.03N/A-300.00%Miss-103.8%N/AN/AOct 10, 2019N/A
    Jun 30, 2019-$0.03-$0.03N/A0.00%In lineN/AN/AN/AAug 9, 2019$5.23M
    Mar 31, 2019-$0.11$0.20N/A-155.00%MissN/AN/AN/AMay 13, 2019$4.83M
    Dec 31, 2018$4.40$6.00N/A-26.67%MissN/AN/AN/AMar 20, 2019$5.92M
    Sep 30, 2018$3.20-$1.60N/A+300.00%BeatN/AN/AN/ANov 7, 2018$6.00M
    Jun 30, 2018-$2.00-$9.20N/A+78.26%BeatN/AN/AN/AAug 2, 2018$5.65M
    Mar 31, 2018-$6.40-$5.40N/A-18.52%MissN/AN/AN/AMay 9, 2018$5.76M
    Dec 31, 2017-$10.00-$11.20N/A+10.71%BeatN/AN/AN/AMar 6, 2018$5.30M
    Sep 30, 2017-$2.80-$8.40N/A+66.67%BeatN/AN/AN/ANov 7, 2017$5.20M
    Jun 30, 2017-$2.80-$14.00N/A+80.00%BeatN/AN/AN/AAug 2, 2017$5.55M
    Mar 31, 2017-$1.60-$15.60N/A+89.74%BeatN/AN/AN/AMay 3, 2017$5.23M
    Dec 31, 2016-$8.80-$7.60N/A-15.79%MissN/AN/AN/AMar 6, 2017$5.98M
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$7.88, after -$2,688.78 the year before. It was -$62.00 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$7.88N/A
    Dec 31, 2024-$2,688.78N/A
    Dec 31, 2023-$430.18N/A
    Dec 31, 2022-$1,388.19N/A
    Dec 31, 2021-$12,753.41-7970981.3%
    Dec 31, 2020$0.16N/A
    Dec 31, 2019-$0.71N/A
    Dec 31, 2018-$0.80N/A
    Dec 31, 2017-$17.20N/A
    Dec 31, 2016-$62.00N/A

    Frequently Asked Questions About ERNA

    When is Ernexa Therapeutics's next earnings date?

    Ernexa Therapeutics's next earnings report is expected for Mar 11, 2027.

    Did ERNA beat earnings estimates last quarter?

    Yes. Ernexa Therapeutics reported EPS of -$1.89 for the quarter ended Sep 30, 2026, above the -$3.84 estimate, a 50.78% surprise.

    How often does ERNA beat earnings estimates?

    Ernexa Therapeutics beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -217.72%.